» Authors » Michaela Kuhlen

Michaela Kuhlen

Explore the profile of Michaela Kuhlen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 94
Citations 1526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuhlen M, Kunstreich M, Eilsberger F, Luster M, Redlich A
Eur Thyroid J . 2025 Mar; 14(1). PMID: 40023147
Introduction: This case report aims to discuss the development of fatal lung fibrosis in a young boy following treatment of metastasized differentiated thyroid carcinoma (DTC). Case Presentation: A 3.6-year-old boy...
2.
Kunstreich M, Ronckers C, Lorenz K, Wolf S, Lessel L, Rohrer T, et al.
Thyroid . 2024 Dec; 35(1):18-30. PMID: 39699646
Among childhood cancer survivors, the cumulative incidence rate of differentiated thyroid carcinomas (DTCs) is estimated to be 8-11%. Although the association of DTC with prior radiotherapy is well-studied, the association...
3.
Kuhlen M, Fruhwald M
World J Pediatr . 2024 Dec; 21(2):120-122. PMID: 39695048
No abstract available.
4.
Kuhlen M, Weins A, Stadler N, Angelova-Toshkina D, Fruhwald M
World J Pediatr . 2024 Dec; 21(2):131-148. PMID: 39641826
Purpose: Cancer predisposition syndromes are genetic disorders that significantly raise the risk of developing malignancies. Although the malignant manifestations of cancer predisposition syndromes are well-studied, recognizing their non-malignant features is...
5.
Kotsis F, Kunstreich M, Redlich A, Rhein K, Ganner A, Walz G, et al.
J Kidney Cancer VHL . 2024 Nov; 11(4):15-27. PMID: 39588063
Early identification of patients at risk with von Hippel-Lindau (VHL) syndrome-related pheochromocytoma and paraganglioma (PPGL) is crucial to prevent morbidity. We investigated the current surveillance recommendations in VHL-related PPGL in...
6.
Kuhlen M, Schaller T, Dintner S, Stadler N, Hofmann T, Schmutz M, et al.
Int J Mol Sci . 2024 Nov; 25(21). PMID: 39519042
Undifferentiated embryonal sarcoma of the liver is a rare mesenchymal malignancy that predominantly occurs in children. The relationship between this tumor entity and germline pathogenic variants (PVs) remains undefined. Here,...
7.
Kuhlen M, Wellbrock M, Kunstreich M, Trubenbach C, Ronckers C, Redlich A, et al.
Thyroid . 2024 Oct; 34(12):1540-1550. PMID: 39474673
The increasing incidence of differentiated thyroid carcinoma (DTC) in children and adolescents has become a growing concern. This study provides the first extensive assessment of incidence patterns and temporal trends...
8.
Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A, et al.
Nat Rev Endocrinol . 2024 Aug; 20(12):760. PMID: 39191988
No abstract available.
9.
Casey R, Hendriks E, Deal C, Waguespack S, Wiegering V, Redlich A, et al.
Nat Rev Endocrinol . 2024 Aug; 20(12):729-748. PMID: 39147856
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and adolescence. Up to 70-80% of childhood PPGL are hereditary, accounting for...
10.
Riedmeier M, Agarwal S, Antonini S, Costa T, Diclehan O, Fassnacht M, et al.
Eur J Endocrinol . 2024 Jun; 191(1):64-74. PMID: 38924056
Objective: Pediatric adrenocortical carcinoma (pACC) is rare, and prognostic stratification remains challenging. We aimed to confirm the prognostic value of the previously published pediatric scoring system (pS-GRAS) in an international...